Publicaciones en las que colabora con Ramón Eritja Casadellà (10)

2021

  1. Correlation between biophysical properties of niosomes elaborated with chloroquine and different tensioactives and their transfection efficiency

    Pharmaceutics, Vol. 13, Núm. 11

2020

  1. Brain Angiogenesis Induced by Nonviral Gene Therapy with Potential Therapeutic Benefits for Central Nervous System Diseases

    Molecular pharmaceutics, Vol. 17, Núm. 6, pp. 1848-1858

  2. Niosome-based approach for in situ gene delivery to retina and brain cortex as immune-privileged tissues

    Pharmaceutics, Vol. 12, Núm. 3

  3. Non-viral mediated gene therapy in human cystic fibrosis airway epithelial cells recovers chloride channel functionality

    International Journal of Pharmaceutics, Vol. 588

2016

  1. The influence of the polar head-group of synthetic cationic lipids on the transfection efficiency mediated by niosomes in rat retina and brain

    Biomaterials, Vol. 77, pp. 267-279

  2. The role of helper lipids in the intracellular disposition and transfection efficiency of niosome formulations for gene delivery to retinal pigment epithelial cells

    International Journal of Pharmaceutics, Vol. 503, Núm. 1-2, pp. 115-126

2015

  1. New Insights into Gene Delivery to Human Neuronal Precursor NT2 Cells: A Comparative Study between Lipoplexes, Nioplexes, and Polyplexes

    Molecular Pharmaceutics, Vol. 12, Núm. 11, pp. 4056-4066

  2. Niosomes based on synthetic cationic lipids for gene delivery: The influence of polar head-groups on the transfection efficiency in HEK-293, ARPE-19 and MSC-D1 cells

    Organic and Biomolecular Chemistry, Vol. 13, Núm. 4, pp. 1068-1081

  3. Protamine/DNA/niosome ternary nonviral vectors for gene delivery to the retina: The role of protamine

    Molecular Pharmaceutics, Vol. 12, Núm. 10, pp. 3658-3671

2014

  1. A novel cationic niosome formulation for gene delivery to the retina

    Journal of Controlled Release, Vol. 174, Núm. 1, pp. 27-36